EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Far fewer people who could benefit from statins ...

Background: Statins, acknowledged for their ability to reduce cardiovascular risk, demonstrate a variety of pleiotropic effects, including anti-inflammatory, antithrombotic, endothelial stabilizing ...

Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s a math problem with life-and-death ...

2024 NOV 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily-- Fresh data on Managed Care are presented in a new report. According to news reporting originating from ...

– 87.1% of Patients Treated with Combination of Obicetrapib and Ezetimibe Met Guideline-Recommended LDL-C Goal of <55 mg/dL compared to 0% of Patients Treated with Placebo (p<0.05) – – New Data ...

A landmark Lancet analysis of more than 150,000 trial participants challenges decades of statin side-effect warnings and calls for updated drug labels grounded in randomized evidence. Study: ...

The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...

SILVER SPRING, Md., Dec 13 (Reuters) - A Merck & Co Inc study failed to show that consumers could make appropriate decisions about whether to take a proposed over-the-counter version of cholesterol ...